Literature DB >> 22298998

Managing pain in inflammatory bowel disease.

Michael J Docherty1, R Carter W Jones, Mark S Wallace.   

Abstract

Pain is a common complaint in inflammatory bowel disease, and it has significant consequences for patients' quality of life. A thorough evaluation to determine the source of patients' pain should include clinical, laboratory, radiologic, and endoscopic assessments as indicated. Differentiating among active inflammation, secondary complications, and functional pain can be complicated. Even when all active disease is adequately treated, clinicians are often left with the difficulty of managing chronic pain. This paper will review the benefits and limitations of several commonly used treatments and promising future therapies. A suggested treatment algorithm will provide some guidance in this challenging area of inflammatory bowel disease management.

Entities:  

Keywords:  Inflammatory bowel disease; irritable bowel syndrome; management; pain

Year:  2011        PMID: 22298998      PMCID: PMC3264972     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  108 in total

1.  Characterization of mouse lumbar splanchnic and pelvic nerve urinary bladder mechanosensory afferents.

Authors:  Linjing Xu; G F Gebhart
Journal:  J Neurophysiol       Date:  2007-11-14       Impact factor: 2.714

2.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

Review 3.  Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease?

Authors:  Linda A Feagins; Byron L Cryer
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

4.  Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics.

Authors:  J T Edwards; G L Radford-Smith; T H Florin
Journal:  J Gastroenterol Hepatol       Date:  2001-11       Impact factor: 4.029

5.  Avoiding the vicious cycle of prolonged opioid use in Crohn's disease.

Authors:  Jennifer L Jones; Edward V Loftus
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

6.  Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.

Authors:  Uma Mahadevan; Edward V Loftus; William J Tremaine; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

7.  The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease.

Authors:  E A Walker; M D Gelfand; A N Gelfand; F Creed; W J Katon
Journal:  Gen Hosp Psychiatry       Date:  1996-07       Impact factor: 3.238

8.  Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial.

Authors:  Gary Tabas; Mary Beaves; Jiping Wang; Paul Friday; Houssam Mardini; George Arnold
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

Review 9.  Chronic pain and medullary descending facilitation.

Authors:  Frank Porreca; Michael H Ossipov; G F Gebhart
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

Review 10.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

View more
  19 in total

1.  Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids.

Authors:  Mohamed Noureldin; Peter D R Higgins; Shail M Govani; Shirley Cohen-Mekelburg; Brooke C Kenney; Ryan W Stidham; Jennifer F Waljee; Akbar K Waljee
Journal:  Aliment Pharmacol Ther       Date:  2018-11-14       Impact factor: 8.171

2.  Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue.

Authors:  Lars-Petter Jelsness-Jørgensen; Svein-Oskar Frigstad; Bjørn Moum; Tore Grimstad; Randi Opheim; Jørgen Jahnsen; Tomm Bernklev
Journal:  United European Gastroenterol J       Date:  2016-10-06       Impact factor: 4.623

3.  Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's Disease.

Authors:  Nathan J Pauly; Lamprinos Michailidis; Michael G Kindred; Deborah Flomenhoft; Michelle R Lofwall; Sharon L Walsh; Jeffery C Talbert; Terrence A Barrett
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

Review 4.  Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.

Authors:  Vassiliki Sinopoulou; Morris Gordon; Anthony K Akobeng; Marco Gasparetto; Michael Sammaan; Jessica Vasiliou; Terence M Dovey
Journal:  Cochrane Database Syst Rev       Date:  2021-11-29

5.  Managing intestinal failure in inflammatory bowel disease - 'when the drugs don't work'.

Authors:  James Morgan; Ashley Bond; Cecil Kullu; Sreedhar Subramanian; Martyn Dibb; Philip J Smith
Journal:  Frontline Gastroenterol       Date:  2020-06-19

6.  Postoperative Pain Management in Patients With Ulcerative Colitis.

Authors:  Norika Katagiri; Ryutaro Sakai; Takashi Izutsu; Hiromasa Kawana; Shigekazu Sugino; Kanta Kido
Journal:  Anesth Prog       Date:  2020-09-01

7.  The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients.

Authors:  Shirley Cohen-Mekelburg; Russell Rosenblatt; Stephanie Gold; Robert Burakoff; Akbar K Waljee; Sameer Saini; Bruce R Schackman; Ellen Scherl; Carl Crawford
Journal:  J Crohns Colitis       Date:  2018-08-29       Impact factor: 9.071

Review 8.  Reducing Pain in Experimental Models of Intestinal Inflammation Affects the Immune Response.

Authors:  Laura Golusda; Anja A Kühl; Britta Siegmund; Daniela Paclik
Journal:  Inflamm Bowel Dis       Date:  2022-05-04       Impact factor: 7.290

9.  'It's about willpower in the end. You've got to keep going': a qualitative study exploring the experience of pain in inflammatory bowel disease.

Authors:  Louise Sweeney; Rona Moss-Morris; Wladyslawa Czuber-Dochan; Laure Belotti; Zoe Kabeli; Christine Norton
Journal:  Br J Pain       Date:  2019-04-11

10.  What Is a Flare? The Manitoba Living With IBD Study.

Authors:  Kelcie Witges; Kathryn Sexton; Lesley A Graff; Laura E Targownik; Lisa M Lix; Clove Haviva; James Stone; Leigh Anne Shafer; Kathy Vagianos; Charles N Bernstein
Journal:  Inflamm Bowel Dis       Date:  2022-06-03       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.